NCT06452212

Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients

A Non-Interventional, Modified Delphi Study to Establish Consensus Recommendations on the Optimal Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Patients in South Korea

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 23 (actual)
• Sponsor: Astellas Pharma Korea, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to establish an expert consensus recommendations on managing patients with mHSPC in South Korea, and to provide clinicians with a comprehensive guide to support their clinical decision making. There are no secondary objectives for this study.

Detailed description

Data collection for this study will be conducted through 2 rounds of web-based surveys of health care professionals (HCPs). A meeting with the panelists will be held as a 3rd round if a consensus for pre determined key questions is not achieved after the 2 rounds of the survey.

Conditions

• Metastatic Hormone-Sensitive Prostate Cancer

Interventions

Type	Name	Description
OTHER	No Intervention	No investigational drug will be administered to participants in this study.

Timeline

• Start date: 2024-07-10
• Primary completion: 2024-07-29
• Completion: 2024-07-29
• First posted: 2024-06-11
• Last updated: 2024-11-21

Locations

1 site across 1 country: South Korea